1-6 of 6
Dennis J. Ahnen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial

Audrey H. Calderwood, John A. Baron, Leila A. Mott, Dennis J. Ahnen, Roberd M. Bostick, Jane C. Figueiredo, Michael N. Passarelli, Judy R. Rees, Douglas J. Robertson, Elizabeth L. Barry
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2019) 12 (5): 295–304.
https://doi.org/10.1158/1940-6207.CAPR-19-0023
Published: 01 May 2019
View articletitled, No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial
Open the PDF for No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial in another window
Includes: Supplementary data
Journal Articles

Urinary Metabolites of Prostanoids and Risk of Recurrent Colorectal Adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS)

Veronika Fedirko, Patrick T. Bradshaw, Jane C. Figueiredo, Robert S. Sandler, Elizabeth L. Barry, Dennis J. Ahnen, Ginger L. Milne, Robert S. Bresalier, John A. Baron
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (11): 1061–1068.
https://doi.org/10.1158/1940-6207.CAPR-15-0212
Published: 02 November 2015
View articletitled, Urinary Metabolites of Prostanoids and Risk of Recurrent Colorectal Adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS)
Open the PDF for Urinary Metabolites of Prostanoids and Risk of Recurrent Colorectal Adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS) in another window
Includes: Supplementary data
Journal Articles

Design and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma Prevention

Patricia Thompson, Denise J. Roe, Liane Fales, Julie Buckmeier, Fang Wang, Stanley R. Hamilton, Achyut Bhattacharyya, Sylvan Green, Chiu-Hsieh Hsu, H.-H. Sherry Chow, Dennis J. Ahnen, C. Richard Boland, Russell I. Heigh, David E. Fay, Maria Elena Martinez, Elizabeth Jacobs, Erin L. Ashbeck, David S. Alberts, Peter Lance
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2012) 5 (12): 1381–1393.
https://doi.org/10.1158/1940-6207.CAPR-12-0204
Published: 04 December 2012
View articletitled, Design and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma Prevention
Open the PDF for Design and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma Prevention in another window
Journal Articles

Variants Downstream of the Ornithine Decarboxylase Gene Influence Risk of Colorectal Adenoma and Aspirin Chemoprevention

Elizabeth L. Barry, Leila A. Mott, Robert S. Sandler, Dennis J. Ahnen, John A. Baron
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (12): 2072–2082.
https://doi.org/10.1158/1940-6207.CAPR-11-0300
Published: 04 December 2011
View articletitled, Variants Downstream of the Ornithine Decarboxylase Gene Influence Risk of Colorectal Adenoma and Aspirin Chemoprevention
Open the PDF for Variants Downstream of the Ornithine Decarboxylase Gene Influence Risk of Colorectal Adenoma and Aspirin Chemoprevention in another window
Journal Articles

Sulindac Metabolites Induce Proteosomal and Lysosomal Degradation of the Epidermal Growth Factor Receptor

Heather A. Pangburn, Dennis J. Ahnen, Pamela L. Rice
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (4): 560–572.
https://doi.org/10.1158/1940-6207.CAPR-09-0159
Published: 04 April 2010
View articletitled, Sulindac Metabolites Induce Proteosomal and Lysosomal Degradation of the Epidermal Growth Factor Receptor
Open the PDF for Sulindac Metabolites Induce Proteosomal and Lysosomal Degradation of the Epidermal Growth Factor Receptor in another window
Includes: Supplementary data
Journal Articles

Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

Frank L. Meyskens, Jr., Christine E. McLaren, Daniel Pelot, Sharon Fujikawa-Brooks, Philip M. Carpenter, Ernest Hawk, Gary Kelloff, Michael J. Lawson, Jayashri Kidao, John McCracken, C. Gregory Albers, Dennis J. Ahnen, D. Kim Turgeon, Steven Goldschmid, Peter Lance, Curt H. Hagedorn, Daniel L. Gillen, Eugene W. Gerner
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2008) 1 (1): 32–38.
https://doi.org/10.1158/1940-6207.CAPR-08-0042
Published: 09 June 2008
View articletitled, Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
Open the PDF for Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial in another window
Includes: Supplementary data